118 related articles for article (PubMed ID: 38805940)
1. Cost-avoidance associated with implementation of an overnight emergency medicine pharmacist at a Level I Trauma, Comprehensive Stroke Center.
Nguyen MH; Gordon K; Reachi B; Bair J; Chauv S; Fontaine GV
Am J Emerg Med; 2024 May; 82():63-67. PubMed ID: 38805940
[TBL] [Abstract][Full Text] [Related]
2. Evaluating reduction in medical costs associated with pharmacists' presence in the emergency department using a novel cost avoidance framework.
Poremba M; Champa K; Reichert E
Am J Health Syst Pharm; 2023 Aug; 80(Suppl 3):S111-S118. PubMed ID: 36525567
[TBL] [Abstract][Full Text] [Related]
3. PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study.
Rech MA; Adams W; Smetana KS; Gurnani PK; Van Berkel Patel MA; Peppard WJ; Hammond DA; Flannery AH
Crit Care Explor; 2021 Apr; 3(4):e0406. PubMed ID: 33912836
[TBL] [Abstract][Full Text] [Related]
4. PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.
Rech MA; Gurnani PK; Peppard WJ; Smetana KS; Van Berkel MA; Hammond DA; Flannery AH
Crit Care Explor; 2021 Dec; 3(12):e0594. PubMed ID: 34913039
[TBL] [Abstract][Full Text] [Related]
5. Impact of an emergency medicine pharmacist on door to needle alteplase time and patient outcomes in acute ischemic stroke.
Barbour J; Hushen P; Newman GC; Vidal J
Am J Emerg Med; 2022 Jan; 51():358-362. PubMed ID: 34823191
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics: PHARM-PEDS Study.
Kiskaddon AL; Smith MM; Gilliland F; Rech MA
Crit Care Explor; 2023 Oct; 5(10):e0980. PubMed ID: 37811129
[TBL] [Abstract][Full Text] [Related]
7. Development of an emergency medicine pharmacy intensity score tool.
Weant KA; Acquisto NM; Doyno CR; Gregory H; Rech MA; Schlobohm CJ; Smith AP; Won KJ
Am J Health Syst Pharm; 2023 Feb; 80(4):215-221. PubMed ID: 36322132
[TBL] [Abstract][Full Text] [Related]
8. Implementation of pharmacist targeted discharge prescription review in an emergency department.
Lineberry E; Rozycki E; Jordan TA; Mellett J; North AM
Am J Emerg Med; 2021 Oct; 48():288-294. PubMed ID: 34023809
[TBL] [Abstract][Full Text] [Related]
9. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
10. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
11. Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosis.
Georgieva D; Markley B; DeClercq J; Choi L; Zuckerman AD
J Manag Care Spec Pharm; 2024 Apr; 30(4):336-344. PubMed ID: 38555624
[TBL] [Abstract][Full Text] [Related]
12. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
13. Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study.
Houso A; Hamdan M; Falana H
Saudi Pharm J; 2022 Dec; 30(12):1718-1724. PubMed ID: 36601501
[TBL] [Abstract][Full Text] [Related]
14. Documentation of pharmacists' interventions in an emergency department and associated cost avoidance.
Lada P; Delgado G
Am J Health Syst Pharm; 2007 Jan; 64(1):63-8. PubMed ID: 17189582
[TBL] [Abstract][Full Text] [Related]
15. Emergency Medicine Pharmacist Impact on Door-to-Needle Time in Patients With Acute Ischemic Stroke.
Jacoby JS; Draper HM; Dumkow LE; Farooq MU; DeYoung GR; Brandt KL
Neurohospitalist; 2018 Apr; 8(2):60-65. PubMed ID: 29623155
[TBL] [Abstract][Full Text] [Related]
16. Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network.
Belcher RM; Blair A; Chauv S; Hoang Q; Hickman AW; Peng M; Baldwin M; Koch L; Nguyen M; Guidry D; Fontaine GV
Crit Care Explor; 2023 Jan; 5(1):e0839. PubMed ID: 36660010
[TBL] [Abstract][Full Text] [Related]
17. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
[TBL] [Abstract][Full Text] [Related]
18. Emergency medicine pharmacist interventions reducing exposure to costs (EMPIRE-C).
Dietrich SK; Bushong BT; Schneider-Smith EA; Mixon MA
Am J Emerg Med; 2022 Apr; 54():178-183. PubMed ID: 35158260
[TBL] [Abstract][Full Text] [Related]
19. Description of telepharmacy services by emergency medicine pharmacists.
Manuel FC; Wieruszewski ED; Brown CS; Russi CS; Mattson AE
Am J Health Syst Pharm; 2022 May; 79(11):873-880. PubMed ID: 35084439
[TBL] [Abstract][Full Text] [Related]
20. Integration of a clinical pharmacist into a Canadian, urban emergency department: a prospective observational study.
Dryden L; Dewhurst NF
Int J Pharm Pract; 2019 Apr; 27(2):175-179. PubMed ID: 30079985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
